Literature DB >> 990187

The Negro variety of hereditary persistence of fetal haemoglobin is a mild form of thalassaemia.

S Charache, J B Clegg, D J Weatherall.   

Abstract

Further studies have been carried out on blood of the 15-year-old Negro male from Baltimore who was the first reported case of the homozygous state for hereditary persistence of fetal haemoglobin. His red cells contain only Hb F; Hbs A and A2 have never been detected. Over a 15-year period of follow up the red cells of this individual have shown persistent microcytosis with reduced MCH and MCV values. His whole-blood p50 value is decreased, probably because of lack of interaction between Hb F and 2,3-diphosphoglycerate. However, his haemoglobin level at the age of 15 years is lower than would be predicted from the degree of increased oxygen affinity. Globin-chain synthesis studies suggest that this is because he has a mild thalassaemia disorder with an alpha/gamma-chain production ratio of about 1.5, similar to that found in beta-thalassemia heterozygotes. Thus Negro HPFH appears to be a well-compensated form of delta beta thalassaemia.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 990187     DOI: 10.1111/j.1365-2141.1976.tb03599.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  4 in total

1.  Effects of human gamma-globin in murine beta-thalassaemia.

Authors:  Tamon Nishino; Hua Cao; George Stamatoyannopoulos; David W Emery
Journal:  Br J Haematol       Date:  2006-07       Impact factor: 6.998

2.  Heterogeneity in the molecular basis of three types of hereditary persistence of fetal hemoglobin and the relative synthesis of the G gamma and A gamma types of gamma chain.

Authors:  A Kutlar; M B Gardiner; M G Headlee; A L Reese; M P Cleek; S Nagle; P K Sukumaran; T H Huisman
Journal:  Biochem Genet       Date:  1984-02       Impact factor: 1.890

3.  G gamma delta beta thalassaemia and g gamma HPFH (Hb Kenya type): comparison of 2 new cases.

Authors:  W G Wood; J B Clegg; D J Weatherall; O H Gyde; D A Obeid; M J Tarlow; M J Brown; S Hewitt
Journal:  J Med Genet       Date:  1977-08       Impact factor: 6.318

4.  The new self-inactivating lentiviral vector for thalassemia gene therapy combining two HPFH activating elements corrects human thalassemic hematopoietic stem cells.

Authors:  Eleni Papanikolaou; Maria Georgomanoli; Evangelos Stamateris; Fottes Panetsos; Markisia Karagiorga; Panagiotis Tsaftaridis; Stelios Graphakos; Nicholas P Anagnou
Journal:  Hum Gene Ther       Date:  2011-12-05       Impact factor: 5.695

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.